salicylaldehyde isonicotinoyl hydrazone has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arosio, P; David, S; Jeong, SY; Ponka, P; Rathore, KI; Schulz, K | 1 |
1 other study(ies) available for salicylaldehyde isonicotinoyl hydrazone and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis.
Topics: Age Factors; Aldehydes; Amyotrophic Lateral Sclerosis; Animals; Body Weight; Cation Transport Proteins; Central Nervous System; Cyclooxygenase 1; Disease Models, Animal; Disease Progression; Ferrozine; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Homeostasis; Hydrazones; Indoles; Iron; Iron Chelating Agents; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Mutation; Phosphopyruvate Hydratase; Receptors, Transferrin; Sciatic Neuropathy; Superoxide Dismutase | 2009 |